{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T10:15:01Z","timestamp":1789467301438,"version":"build-2803163510"},"reference-count":56,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2008,11,6]],"date-time":"2008-11-06T00:00:00Z","timestamp":1225929600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intl Journal of Cancer"],"published-print":{"date-parts":[[2009,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>For more than 50 years, links between autoimmunity and lymphomas have been described based on human and animal studies. Over the last 3 decades, many studies have addressed specific hypotheses about these associations using population level data. This has been accomplished by assessing previous autoimmune history in case\u2013control studies of patients with lymphoma (mainly non\u2010Hodgkin lymphoma) and myeloma, and by following cohorts of patients with various autoimmune diseases for subsequent development of lymphoma and multiple myeloma. In this article, we review our recently published series of association studies based on data from Scandinavia and from US Veterans and other relevant findings. We also discuss what these associations have revealed about the mechanisms and pathways underlying both autoimmunity and lymphoma. Finally, we discuss the future directions involving a combination of population and molecular studies that are needed to better define underlying biological mechanisms. Published 2008 Wiley\u2010Liss, Inc.<\/jats:p>","DOI":"10.1002\/ijc.24141","type":"journal-article","created":{"date-parts":[[2008,11,6]],"date-time":"2008-11-06T20:33:44Z","timestamp":1226003624000},"page":"1497-1502","source":"Crossref","is-referenced-by-count":99,"title":["Autoimmunity and lymphomagenesis"],"prefix":"10.1002","volume":"124","author":[{"given":"Lynn R.","family":"Goldin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ola","family":"Landgren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,1,27]]},"reference":[{"key":"e_1_2_6_2_2","volume-title":"Pathology and genetics of tumours of haematopoietic and lymphoid tissues","author":"Jaffe ES","year":"2001"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.22719"},{"key":"e_1_2_6_4_2","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1182\/blood.V27.4.435.435","article-title":"Autoimmune disease in NZB\u2010Bl mice. II. Autoimmunity and malignant lymphoma","volume":"27","author":"Mellors RC","year":"1966","journal-title":"Blood"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.165.20.2337"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2007.06.033"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-11-4620"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djj361"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.21745"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.23267"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1097\/00001648-200011000-00012"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-10-121285"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2008.4"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2007.06859.x"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-10-119974"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djj004"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.22277"},{"key":"e_1_2_6_18_2","article-title":"Population\u2010based study of autoimmune conditions and the risk of specific lymphoid malignancies","author":"Anderson LA","journal-title":"Int J Cancer"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-03-012948"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/0959-8049(96)00210-9"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kel444"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0215(20001101)88:3<497::AID-IJC27>3.0.CO;2-J"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/85.4.307"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2005.1.340"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa01133202"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-03-0801"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1038\/ni0901-793"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V14.10.1151.1151"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1038\/ncprheum0620"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1177\/0961203308092164"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2006.04.004"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2004.02.009"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI0214121"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.297.18.2010"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-08-044008"},{"key":"e_1_2_6_36_2","first-page":"1697","article-title":"Respiratory tract infections in the pathway to multiple myeloma: a population\u2010based study in Scandinavia","volume":"91","author":"Landgren O","year":"2006","journal-title":"Haematologica"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-06-1056"},{"key":"e_1_2_6_38_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.20021"},{"key":"e_1_2_6_39_2","doi-asserted-by":"publisher","DOI":"10.1080\/17402520600876911"},{"key":"e_1_2_6_40_2","doi-asserted-by":"publisher","DOI":"10.1080\/17402520600876762"},{"key":"e_1_2_6_41_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ken005"},{"key":"e_1_2_6_42_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-006-0040-5"},{"key":"e_1_2_6_43_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2007.06810.x"},{"key":"e_1_2_6_44_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.10939"},{"key":"e_1_2_6_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(85)90242-6"},{"key":"e_1_2_6_46_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.11.3909"},{"key":"e_1_2_6_47_2","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.8.13.2089"},{"key":"e_1_2_6_48_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1996.14.6.1943"},{"key":"e_1_2_6_49_2","first-page":"1095","article-title":"Non\u2010Hodgkin's lymphoma in patients with rheumatoid arthritis treated with low dose methotrexate","volume":"23","author":"Usman AR","year":"1996","journal-title":"J Rheumatol"},{"key":"e_1_2_6_50_2","first-page":"173","article-title":"The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A\u2010prednisone immunosuppression","volume":"133","author":"Nalesnik MA","year":"1988","journal-title":"Am J Pathol"},{"key":"e_1_2_6_51_2","first-page":"47","article-title":"Epstein\u2010Barr virus, methotrexate, and lymphoma in patients with rheumatoid arthritis and primary Sjogren's syndrome: case series","volume":"28","author":"Dawson TM","year":"2001","journal-title":"J Rheumatol"},{"key":"e_1_2_6_52_2","first-page":"322","article-title":"Lymphoproliferative disorders in rheumatoid arthritis: clinicopathological analysis of 76 cases in relation to methotrexate medication","volume":"34","author":"Hoshida Y","year":"2007","journal-title":"J Rheumatol"},{"key":"e_1_2_6_53_2","first-page":"1245","article-title":"B cell\u2010targeted therapy in autoimmune disease: rationale, mechanisms, and clinical application","volume":"35","author":"Mease PJ","year":"2008","journal-title":"J Rheumatol"},{"key":"e_1_2_6_54_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.181.5.3674"},{"key":"e_1_2_6_55_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-10-3563"},{"key":"e_1_2_6_56_2","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.11822"},{"key":"e_1_2_6_57_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-007-8001-x"}],"container-title":["International Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fijc.24141","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ijc.24141","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T09:30:46Z","timestamp":1697448646000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ijc.24141"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1,27]]},"references-count":56,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["10.1002\/ijc.24141"],"URL":"https:\/\/doi.org\/10.1002\/ijc.24141","archive":["Portico"],"relation":{},"ISSN":["0020-7136","1097-0215"],"issn-type":[{"value":"0020-7136","type":"print"},{"value":"1097-0215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,1,27]]}}}